Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Amiloride Nasal Spray in Healthy Volunteers
NCT04181008Phase 1Completed
- Sponsor
- University of Utah
- Start
- Sep 2020
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of amiloride in anxiety disorder (3 arms), sponsored by University of Utah. Primary endpoints: Amiloride plasma concentration at 24 hours, Time to reach maximum plasma concentration at 24 hours and 4 more. Started Sep 2020; status: completed.
02
Drugs
amiloride
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT04181008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04181008.